To strengthen the immunotherapeutic approach, we knocked out the USP32 in CRC cells, resulting in reduced cell proliferation, migration, invasion, and colony formation through a reduction in PD-L1 protein levels. The gene discussed is USP32; the disease is colorectal carcinoma.